NCT05174871Active, not recruiting
Time-Restricted Feeding in Children and Adolescents With Obesity
Source: ClinicalTrials.gov · Last updated 23 Mar 2026
Brief summary (registry, in English)
This study will evaluate the effectiveness of a 2-month time-restricted feeding (TRF) intervention in children and adolescents with obesity. The investigators will determine whether the potential beneficial effects of the intervention in this population are maintained over time. Furthermore, potential mechanisms mediating TRF effects will be explored, specifically focusing on the potential role of the gut microbiome and the circadian rhythm.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 67 (actual)
- First submitted
- 14 Dec 2021
- Start date
- 4 Jan 2022
- Primary completion date
- 31 May 2023
- Lead sponsor
- Fundació Sant Joan de Déu
- Diseases
- Obesity
- NCT number
- NCT05174871
What you commit to
- Study type: Interventional
- Participants enrolled: 67
- From 4 Jan 2022 to the primary completion date, 31 May 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Bariatric surgery
- Under drug treatment with a prescription change in the last 3 months
Other illness
- Diabetes with insulin treatment
Other
- Spontaneous time-restricted feeding for \> 12 hours
- Pregnancy
- Intellectual disability
Who the study is looking for
- Obesity (BMI z score \> 2)
Age in the registry: 8 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Sant Joan de Déu Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.